Concepedia

Author

Lucinda Shaw

Mirna Therapeutics (United States)

Also Known As

Lucinda Shaw

4

Publications

2.3K

Citations

3

H-Index

7

Concepts

All Affiliations

Mirna Therapeutics (United States)
LS

About

Lucinda Shaw is an author at Mirna Therapeutics (United States) specializing in hepatitis, viral hepatitis, and medicinal chemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

1.2K

2

Biomolecular Engineering

1

1

1.2K

3

Immunology

1

1

1.2K

4

Medicinal Chemistry

1

1

1.2K

5

Viral Hepatitis

1

1

1.2K

Lucinda Shaw

×

3

Publications

2.3K

Citations

3

H-Index

YearCitations

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

Jennifer A. Lockridge, Lucinda Shaw, Karin S. Blanchard,

Nature Biotechnology

2005

1.2K

A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing

Jonathan D. Finn, Amy Smith, Mihir Patel,

Cell Reports

2018

801

Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication†

Karin S. Blanchard, Lucinda Shaw, Kristi Jensen,

Hepatology

2005

290

Page 1